Anika Therapeutics Inc. Long-term receivables

Long-term receivables of ANIK for past 10 years: annual, quarterly and twelve month trailing (TTM) including Long-term receivables growth rates and interactive chart.


Highlights and Quick Summary

  • Long-term receivables for the quarter ending June 30, 2016 was $7.57 Million
Visit stockrow.com/ANIK for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Long-term receivables of Anika Therapeutics Inc.

Most recent Long-term receivablesof ANIK including historical data for past 10 years.

Interactive Chart of Long-term receivables of Anika Therapeutics Inc.

Anika Therapeutics Inc. Long-term receivables for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2016 $7.57

Business Profile of Anika Therapeutics Inc.

Sector: Healthcare
Industry: Medical Devices